March 5, 2020updated 21 Oct 2021 11:45am
Roche wins approval for Actemra for coronavirus complications
Swiss healthcare company Roche has secured approval from China for its anti-inflammation drug Actemra (tocilizumab) to treat patients developing severe complications from coronavirus (Covid-19).


